DocGo Inc. Lease, Cost
DocGo Inc. (DCGO) reported Lease, Cost of $3.11 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-17
- DocGo Inc. lease, cost for the quarter ending 2026-06-30 was $3.11M, a 0.56% decline year-over-year.
- DocGo Inc. lease, cost for the quarter ending 2026-03-31 was $3.12M, a 1.07% decline year-over-year.
- DocGo Inc. lease, cost for the quarter ending 2025-12-31 was $3.12M, a 13.45% decline year-over-year.
- DocGo Inc. lease, cost for the quarter ending 2025-09-30 was $2.98M, a 0.35% decline year-over-year.
- DocGo Inc. lease, cost for fiscal 2025 was $12.39M, a 4.80% increase from fiscal 2024.
- DocGo Inc. lease, cost for fiscal 2024 was $11.82M, a 1.91% decline from fiscal 2023.
- DocGo Inc. lease, cost for fiscal 2023 was $12.05M, a 65.24% increase from fiscal 2022.
- DocGo Inc. lease, cost for fiscal 2022 was $7.29M, a 142.57% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 3 month as first filed | Lease, Cost 6 month | Lease, Cost 6 month as first filed | Lease, Cost 9 month | Lease, Cost 9 month as first filed | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.11M 10-Q · filed 2026-08-17 | $6.23M 10-Q · filed 2026-08-17 | $9.35M derived: sum of 3 quarters · filed 2026-08-17 | $12.33M derived: sum of 4 quarters · filed 2026-08-17 | ||||
| 2026-03-31 | $3.12M 10-Q · filed 2026-05-11 | $6.24M derived: sum of 2 quarters · filed 2026-05-11 | $9.22M derived: sum of 3 quarters · filed 2026-05-11 | $12.35M derived: sum of 4 quarters · filed 2026-08-17 | ||||
| 2025-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $6.10M derived: sum of 2 quarters · filed 2026-03-16 | $9.23M derived: sum of 3 quarters · filed 2026-08-17 | $12.39M 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | $2.98M 10-Q · filed 2025-11-10 | $6.12M derived: sum of 2 quarters · filed 2026-08-17 | $9.27M 10-Q · filed 2025-11-10 | $12.87M derived: sum of 4 quarters · filed 2026-08-17 | ||||
| 2025-06-30 | $3.13M 10-Q · filed 2026-08-17 | $6.28M 10-Q · filed 2026-08-17 | $9.89M derived: sum of 3 quarters · filed 2026-08-17 | $12.88M derived: sum of 4 quarters · filed 2026-08-17 | ||||
| 2025-03-31 | $3.15M 10-Q · filed 2026-05-11 | $6.75M derived: sum of 2 quarters · filed 2026-05-11 | $9.75M derived: sum of 3 quarters · filed 2026-05-11 | $12.33M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $6.60M derived: sum of 2 quarters · filed 2026-03-16 | $9.17M derived: sum of 3 quarters · filed 2026-03-16 | $11.82M 10-K · filed 2026-03-16 | ||||
| 2024-09-30 | $3.00M 10-Q · filed 2025-11-10 | $5.57M derived: sum of 2 quarters · filed 2025-11-10 | $8.22M 10-Q · filed 2025-11-10 | $13.57M derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2024-06-30 | $2.58M 10-Q · filed 2025-08-07 | $5.22M 10-Q · filed 2025-08-07 | $10.58M derived: sum of 3 quarters · filed 2026-03-16 | $13.06M derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2024-03-31 | $2.64M 10-Q · filed 2025-05-08 | $1.41M 10-Q · filed 2024-05-08 | $8.00M derived: sum of 2 quarters · filed 2026-03-16 | $10.48M derived: sum of 3 quarters · filed 2026-03-16 | $12.67M derived: sum of 4 quarters · filed 2026-03-16 | |||
| 2023-12-31 | $5.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $7.84M derived: sum of 2 quarters · filed 2026-03-16 | $10.03M derived: sum of 3 quarters · filed 2026-03-16 | $12.05M 10-K · filed 2026-03-16 | $5.10M 10-K · filed 2024-02-28 | |||
| 2023-09-30 | $2.48M 10-Q · filed 2024-11-07 | $1.15M 10-Q · filed 2023-11-06 | $4.67M derived: sum of 2 quarters · filed 2024-11-07 | $6.69M 10-Q · filed 2024-11-07 | $3.48M 10-Q · filed 2023-11-06 | $10.68M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $2.19M 10-Q · filed 2024-08-07 | $1.23M 10-Q · filed 2023-08-08 | $4.21M 10-Q · filed 2024-08-07 | $2.33M 10-Q · filed 2023-08-08 | $8.20M derived: sum of 3 quarters · filed 2025-02-27 | $9.16M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $1.09M 10-Q · filed 2024-05-08 | $6.00M derived: sum of 2 quarters · filed 2025-02-27 | $6.96M derived: sum of 3 quarters · filed 2025-02-27 | $7.67M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $4.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $5.87M derived: sum of 2 quarters · filed 2025-02-27 | $6.57M derived: sum of 3 quarters · filed 2025-02-27 | $7.29M 10-K · filed 2025-02-27 | $3.50M 10-K · filed 2023-03-14 | |||
| 2022-09-30 | $960.81K 10-Q · filed 2023-11-06 | $1.66M derived: sum of 2 quarters · filed 2023-11-06 | $2.38M 10-Q · filed 2023-11-06 | $3.68M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $702.33K 10-Q · filed 2023-08-08 | $1.42M 10-Q · filed 2023-08-08 | $2.72M derived: sum of 3 quarters · filed 2024-02-28 | $3.29M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $717.72K 10-Q · filed 2023-05-09 | $2.02M derived: sum of 2 quarters · filed 2024-02-28 | $2.59M derived: sum of 3 quarters · filed 2024-02-28 | $3.16M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.87M derived: sum of 2 quarters · filed 2024-02-28 | $2.45M derived: sum of 3 quarters · filed 2024-02-28 | $3.01M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $570.78K 10-Q · filed 2022-11-08 | $1.14M derived: sum of 2 quarters · filed 2022-11-08 | $1.70M 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | $572.31K 10-Q · filed 2022-08-09 | $1.13M 10-Q · filed 2022-08-09 | ||||||
| 2021-03-31 | $559.42K 10-Q · filed 2022-05-10 | |||||||
| 2020-12-31 | $2.00M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |